Testing effectiveness (Phase 2)Looking for participantsNCT06247501
What this trial is testing
Treatment of CD19 Chimeric Antigen Receptor T Cells for Pediatric Patients With CD19-positive B-cell Acute Lymphoblastic Leukemia Who Are Indicated for Hematopoietic Stem Cell Transplantation
Who this might be right for
Very High Risk Acute Lymphoblastic LeukemiaCD19 CAR-T Therapy
Seoul National University Hospital 50